Latest discoveries in ADPKD genetics

Living with PKD
Back to Search
Recorded Tuesday September 28, 2021 | 7 p.m. CDT

About

What is the database and what are we learning from it?

Learning objectives

  • Understand how genetic test results can tell us about a PKD patient’s disease progression.
  • Learn how to sign up to participate in genetic research.
  • Increase knowledge of PKDF’s funded research programs and projects.

Questions?

3 + 2 =

Speaker

Peter C. Harris, Ph.D.

Peter C. Harris, Ph.D.

Director, Mayo Clinic Translational PKD Center

The research laboratory of Peter C. Harris, Ph.D., focuses on genetic diseases of the kidney, especially PKD. Dr. Harris’ laboratory employs a range of genetic and cell biological approaches to understand the etiology and pathogenesis of these disorders. Dr. Harris’ research group previously identified the major gene for the common autosomal dominant PKD (ADPKD) and the gene for autosomal recessive PKD (ARPKD). More recently, they identified two genes for the syndromic PKD, Meckel syndrome (MKS), and two minor ADPKD-like genes.

In these disorders, Dr. Harris’ studies are focused on screening for disease-causing mutations and other variants that can modify the phenotype. By employing genotype and phenotype studies, he is determining the extent to which the variability in disease presentation and progression is explained by simple genetic factors.

Dr. Harris’ research is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). He is associate director of the Mayo Translational PKD Center, which coordinates PKD research activities at Mayo Clinic. He also hosts the PKD Foundation-funded ADPKD Mutation Database, which describes more than 2,000 variants to the ADPKD genes.

Related Resources

ARPKD EL-PFDD 2023

ARPKD EL-PFDD 2023

What to Expect from the ARPKD EL-PFDD Meeting On August 29, 2023 the PKD Foundation will hold its first ever Externally Led Patient-focused Drug Development (EL-PFDD) Meeting on Autosomal Recessive PKD (ARPKD) and Congenital Hepatic Fibrosis (CHF). Should you attend the meeting? What should you...

ADPKD Registry Annual Report 2022

ADPKD Registry Annual Report 2022

The PKDF Research team is excited to expand the features available in the ADPKD Registry in summer 2023. This project has been carefully planned and executed with our patients at the center. The last few years have been spent building the largest ADPKD patient-reported outcomes dataset.